16-3727696-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004380.3(CREBBP):c.*22T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,613,564 control chromosomes in the GnomAD database, including 4,061 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.092 ( 2151 hom., cov: 31)
Exomes 𝑓: 0.010 ( 1910 hom. )
Consequence
CREBBP
NM_004380.3 3_prime_UTR
NM_004380.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0430
Publications
5 publications found
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
- Rubinstein-Taybi syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- Rubinstein-Taybi syndrome due to CREBBP mutationsInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Menke-Hennekam syndrome 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 16-3727696-A-G is Benign according to our data. Variant chr16-3727696-A-G is described in ClinVar as [Benign]. Clinvar id is 1230148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CREBBP | NM_004380.3 | c.*22T>C | 3_prime_UTR_variant | Exon 31 of 31 | ENST00000262367.10 | NP_004371.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0922 AC: 14004AN: 151904Hom.: 2135 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
14004
AN:
151904
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0258 AC: 6473AN: 251332 AF XY: 0.0187 show subpopulations
GnomAD2 exomes
AF:
AC:
6473
AN:
251332
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0104 AC: 15247AN: 1461542Hom.: 1910 Cov.: 32 AF XY: 0.00909 AC XY: 6608AN XY: 727096 show subpopulations
GnomAD4 exome
AF:
AC:
15247
AN:
1461542
Hom.:
Cov.:
32
AF XY:
AC XY:
6608
AN XY:
727096
show subpopulations
African (AFR)
AF:
AC:
11042
AN:
33470
American (AMR)
AF:
AC:
985
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
394
AN:
26130
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
72
AN:
86228
European-Finnish (FIN)
AF:
AC:
2
AN:
53282
Middle Eastern (MID)
AF:
AC:
121
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
1161
AN:
1111864
Other (OTH)
AF:
AC:
1470
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
635
1270
1906
2541
3176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0925 AC: 14062AN: 152022Hom.: 2151 Cov.: 31 AF XY: 0.0883 AC XY: 6566AN XY: 74322 show subpopulations
GnomAD4 genome
AF:
AC:
14062
AN:
152022
Hom.:
Cov.:
31
AF XY:
AC XY:
6566
AN XY:
74322
show subpopulations
African (AFR)
AF:
AC:
13102
AN:
41412
American (AMR)
AF:
AC:
644
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
63
AN:
3462
East Asian (EAS)
AF:
AC:
0
AN:
5170
South Asian (SAS)
AF:
AC:
7
AN:
4788
European-Finnish (FIN)
AF:
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
104
AN:
67992
Other (OTH)
AF:
AC:
137
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
494
989
1483
1978
2472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
85
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.